This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2012-2014.
Company Filing History:
Years Active: 2012-2014
Title: Gerd Bader: Innovator in Medicinal Chemistry
Introduction
Gerd Bader is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target diseases characterized by excessive or abnormal cell proliferation.
Latest Patents
Gerd Bader holds 2 patents, with his latest innovations focusing on 6-alkynylpyridines. These compounds serve as SMAC mimetics and are useful as medicaments for the treatment of conditions such as cancer. His inventions include a process for the preparation of 4-heterocycloalkylpyridines, which are suitable for creating pharmaceutical compositions aimed at treating diseases associated with abnormal cell growth.
Career Highlights
Throughout his career, Gerd Bader has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Efriends Energy GmbH. His work in these organizations has contributed to advancements in medicinal chemistry and drug development.
Collaborations
Gerd Bader has collaborated with several professionals in his field, including Andreas Steffen and Maria Impagnatiello. These collaborations have further enhanced his research and development efforts in creating innovative medicinal compounds.
Conclusion
Gerd Bader's contributions to medicinal chemistry, particularly through his patents and collaborations, highlight his role as an influential inventor in the fight against diseases like cancer. His work continues to pave the way for new therapeutic options.